Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Leal Health

Request full access

AI-based marketplace to help patients and community oncologists find advance treatment

Clifton, United StatesFounded 2017Health Tech & Medtech

About Leal Health

Leal Health, formerly known as Trialjectory, operates an AI-powered platform designed to grant cancer patients expedited access to advanced treatments. Founded in 2017 by Tzvia Bader, Avital Gaziel, Guy Gildor, and Noam Geva, the company stems from direct, personal experience with the difficulties of navigating cancer care. CEO Tzvia Bader is a Stage IV melanoma survivor who, after experiencing her mother's struggle with non-Hodgkin lymphoma and then her own, was motivated to fix the broken system for accessing clinical trials. This firsthand knowledge shaped the company's patient-first approach. After spending 20 years building technology companies, Bader saw that AI was the only viable way to empower patients with the information needed to find the best possible treatments.

The company's core offering is a sophisticated decision-support platform that serves multiple stakeholders: patients, healthcare providers, and pharmaceutical companies. For patients, the platform analyzes their specific medical records, including complex genetic data, to generate a personalized and easy-to-understand list of all relevant treatment options, including FDA-approved therapies and clinical trials. A key feature is its predictive capability, which can anticipate future treatment needs as a patient's disease progresses. The service also provides resources for financial aid and schedule management to remove common barriers to care.

For its business clients in the pharmaceutical and biotech industries, Leal Health provides a platform to enhance the design and recruitment for clinical trials. By offering analytics on patient populations and barriers, it helps these companies develop more patient-centric trials, identify suitable candidates more efficiently, and ultimately reduce the time and cost associated with bringing new drugs to market. This dual B2B and B2C model positions the company as a central hub in the oncology ecosystem. The company has received numerous accolades, including being named one of TIME's 100 Best Inventions of 2020 and an honoree in Fast Company's 2021 World-Changing Ideas Awards.

Source: Dealroom company data

At a glance

Status
Operational
Employees
18
Open positions
None listed
Dealroom signal
63.0/100
Industry
Health
Sub-industry
Health Platform
Sector
Oncology, Drug Development, Core AI, Precision Medicine, Tech for Biotech and Pharma, Physician Support Tools, Hard Tech, AI Applications
Technology
Artificial Intelligence, Machine Learning
Business model
Marketplace & ecommerce
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2024 $26M $104M Undisclosed —
SERIES AOther financing Feb 2022 $20M $80M Contour Venture Partners · JAL Ventures · Rho Capital Partners · TIA Ventures ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Leal Health website traffic

Latest recorded traffic for Leal Health is 9.3K monthly website visits, down 33.6% over the last three months. Leal Health's team declined 5.3% over the past year.

Latest monthly visits9.3K 3-month web change-33.6% 1-year team growth-5.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Leal Health in the Clifton ecosystem

Live from Dealroom

The Leal Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A4 investors entered at this stage

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States46.1%
🇮🇱 Israel46.1%
🇩🇪 Germany7.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Leal Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Leal Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.